Company intelligence / Profile preview

Juno Genetics

Ownership: Private
Development stage: Commercial

Overview

Juno Genetics provides clinically validated preimplantation genetic testing for aneuploidy and single gene disorders. Their tests are used by IVF clinics to select embryos most likely to result in successful pregnancies and reduce the risk of passing on genetic conditions. The company has significant experience with hundreds of thousands of embryo tests and collaborates closely with leading IVF clinics and reproductive endocrinologists[1].

Therapeutic areas: Rare DiseasesWomen's Health
Modalities: Diagnostic testGenetic testingPreimplantation genetic testing (PGT)
Industry: Molecular Diagnostics

Partnerships

Collaborations with top IVF clinics and reproductive endocrinologists

Beyond the preview

Go deeper on Juno Genetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Juno Genetics.

Explore the full profile